161 related articles for article (PubMed ID: 3315926)
1. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
Nakajima K
Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions.
Nakajima K; Kuzumaki N; Oda A; Kobayashi H; Katoh H; Tanabe T
Oncology; 1989; 46(4):260-5. PubMed ID: 2662090
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
4. [Expression of ras and erbB2 in benign and malignant lesions of the stomach].
Zhao A; Li J; Lu Y
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):336-9. PubMed ID: 8697969
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
[TBL] [Abstract][Full Text] [Related]
7. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.
Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T
J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957
[TBL] [Abstract][Full Text] [Related]
8. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa.
Karayiannis M; Yiagnisis M; Papadimitriou K; Spandidos DA
Anticancer Res; 1989; 9(6):1505-10. PubMed ID: 2697179
[TBL] [Abstract][Full Text] [Related]
9. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
Gui K
Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
[TBL] [Abstract][Full Text] [Related]
10. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies.
Yoshida K; Hamatani K; Koide H; Abe Y; Ikeda H; Tsuchiyama H; Nakayama E; Shiku H
Cancer Detect Prev; 1988; 12(1-6):369-76. PubMed ID: 3052835
[TBL] [Abstract][Full Text] [Related]
11. [An attempt at using monoclonal antibodies to oncogene products].
Kuzumaki N
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2205-11. PubMed ID: 3300558
[TBL] [Abstract][Full Text] [Related]
12. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
[TBL] [Abstract][Full Text] [Related]
13. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers.
Yoshida K; Hamatani K; Koide H; Ikeda H; Nakamura N; Akiyama M; Tsuchiyama H; Nakayama E; Shiku H
Cancer Res; 1988 Oct; 48(19):5503-9. PubMed ID: 3046740
[TBL] [Abstract][Full Text] [Related]
14. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia.
Czerniak B; Herz F; Gorczyca W; Koss LG
Cancer; 1989 Oct; 64(7):1467-73. PubMed ID: 2550123
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
Yaginuma Y; Yamashita K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
[TBL] [Abstract][Full Text] [Related]
16. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression.
Ierardi E; Francavilla A; Balzano T; Traversa A; Principi M; Monno RA; Amoruso A; Ingrosso M; Pisani A; Panella C
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):214-9. PubMed ID: 9646212
[TBL] [Abstract][Full Text] [Related]
17. Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue.
Going JJ; Williams AR; Wyllie AH; Anderson TJ; Piris J
J Pathol; 1988 Jul; 155(3):185-90. PubMed ID: 3045276
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of ras P21 oncoprotein in human skin lesions.
Zioga C; Malamou-Mitsis VD; Kamina S; Agnantis NJ
Anticancer Res; 1995; 15(3):1015-22. PubMed ID: 7645920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]